Cytosorbents Crp Ownership
| CTSO Stock | USD 1.09 0.04 3.54% |
Shares in Circulation | First Issued 2004-12-31 | Previous Quarter 54.3 M | Current Value 54.5 M | Avarage Shares Outstanding 20.2 M | Quarterly Volatility 17.4 M |
Cytosorbents |
Cytosorbents Stock Ownership Analysis
About 30.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.37. Cytosorbents Crp had not issued any dividends in recent years. The entity had 1:25 split on the 5th of December 2014. Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. Cytosorbents Cor operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people. For more info on Cytosorbents Crp please contact the company at 732 329 8885 or go to https://www.cytosorbents.com.Besides selling stocks to institutional investors, Cytosorbents Crp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cytosorbents Crp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cytosorbents Crp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Cytosorbents Crp Quarterly Liabilities And Stockholders Equity |
|
About 10.0% of Cytosorbents Crp are currently held by insiders. Unlike Cytosorbents Crp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Cytosorbents Crp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Cytosorbents Crp's insider trades
Cytosorbents Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cytosorbents Crp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytosorbents Crp backward and forwards among themselves. Cytosorbents Crp's institutional investor refers to the entity that pools money to purchase Cytosorbents Crp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2024-12-31 | 144.9 K | Advisor Group Holdings, Inc. | 2024-12-31 | 122.4 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 106.6 K | Northern Trust Corp | 2024-12-31 | 91.6 K | Renaissance Technologies Corp | 2024-12-31 | 88 K | Raymond James Finl Svs Advisors, Inc. | 2024-09-30 | 60.6 K | Kestra Advisory Services, Llc | 2024-12-31 | 55 K | Engineers Gate Manager Lp | 2024-12-31 | 52.8 K | Raymond James & Associates | 2024-09-30 | 50 K | Avenir Corporation | 2024-12-31 | 3.1 M | Skylands Capital, Llc | 2024-12-31 | 2.8 M |
Cytosorbents Crp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cytosorbents Crp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cytosorbents Crp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cytosorbents Crp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cytosorbents Crp Outstanding Bonds
Cytosorbents Crp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cytosorbents Crp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cytosorbents bonds can be classified according to their maturity, which is the date when Cytosorbents Crp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.